Navigation Links
Key discovered to how chemotherapy drug causes heart failure
Date:10/28/2012

HOUSTON - Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumors, in some patients.

Scientists have identified an unexpected mechanism via the enzyme Top2b that drives the drug's attack on heart muscle, providing a new approach for identifying patients who can safely tolerate doxorubicin and for developing new drugs. A team led by scientists at The University of Texas MD Anderson Cancer Center reports its findings about the general DNA-damaging drug today in the journal Nature Medicine.

"Even in this age of targeted therapies, doxorubicin remains an effective agent used mainly in combination with other drugs against a variety of malignancies, including breast, lung, ovarian and bladder cancers, as well as leukemia and lymphoma," said Edward T.H. Yeh, M.D., professor and chair of MD Anderson's Department of Cardiology and senior author of the study.

"However, its use is limited by its cardiotoxicity, which can lead to heart failure," Yeh said. "We're excited because we've identified the molecular basis for doxorubicin's damage to the heart."

A tale of two enzymes

Doxorubicin binds to topoisomerase2 (Top2), an enzyme that controls the unwinding of DNA necessary for cell division.

There are two types of Top2, Yeh said. Top2a is overproduced in cancer cells but largely absent in normal cells. The reverse is true for Top2b, virtually absent in cancer cells but present in normal cells.

Doxorubicin destroys cancer cells by binding to Top2a and to DNA, causing irreparable damage in the form of double-strand DNA breaks. This triggers apoptosis, a cellular suicide mechanism designed to prevent the growth of defective cells.

Yeh and colleagues found that the drug binds to Top2b in cardiomyocytes - heart muscle cells - but it inflicts its damage in a different manner from its attack o
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Drug combination against NRAS-mutant melanoma discovered
2. New Brain-Cleaning System Discovered in Mice
3. New regulatory mechanism discovered in cell system for eliminating unneeded proteins
4. Melanoma-promoting gene discovered
5. New mechanism of bacterial pathogenesis discovered
6. Strategy discovered to activate genes that suppress tumors and inhibit cancer
7. Researchers reveal underlying mechanism of powerful chemotherapy for prostate cancer treatment
8. UCI researchers find cause of chemotherapy resistance in melanoma
9. Weizmann Institutes mathematical model may lead to safer chemotherapy
10. Standard chemotherapy provides higher survival rate than experimental in lung cancer patients
11. Adding bavituximab to second-line chemotherapy doubles response rate
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Key discovered to how chemotherapy drug causes heart failure
(Date:5/24/2013)... 24, 2013 A recent study by research ... dreads the upcoming bathing suit season. Almost 138 million people ... heats up due to weight issues and a quarter admit ... PharmaCo Labs recommends that those anxious about their size ... as part of an overall effort to improve diet and ...
(Date:5/24/2013)... Tampa, FL (PRWEB) May 24, 2013 Compromise ... wants to compromise when it comes to sleep and comfort. ... sleep preferences prove highly individual. For some, this can cause ... Bed, a mattress advice blog, tackles eight common issues in ... “ She Wants Soft, He Wants Firm: What to do ...
(Date:5/24/2013)... DePuy ASR lawsuit claims ... move forward in courts throughout the country, Bernstein Liebhard ... San Francisco Superior Court on April 25th, a Plaintiff ... DePuy hip lawsuit is voluntarily seeking dismissal of the ... No. CGC11508806; Calif. Super. Ct., San Francisco). , “This ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 KC and Monica ... Title Sponsors for FreeRide836. Their oldest sons, Kyle and Austin ... Tracey Russell family and several professional kiteboarders. , KC Craichy ... project. "This has miraculously come together such that virtually everyone ... to participate." , 20 kite boarders will meet at Matheson ...
(Date:5/24/2013)... (LA JOLLA, Calif.) (PRWEB) May 24, 2013 ... letter to House Appropriators and the California congressional ... them to restore sequestered industry user fees paid ... 2013, and to ensure that future across-the-board cuts ... as part of the FY14 Agriculture, Rural Development ...
Breaking Medicine News(10 mins):Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3Health News:What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3
... on Kidz-Med ThermofocusWESTON, Fla., May 22 Kidz-Med, Inc., ... ASFX) is excited to see that awareness for a ... surrounding taking a child,s temperature with the Kidz-Med Thermofocus ... show The Doctors , renowned pediatrician Dr. Jim ...
... BELLEVILLE, ON, May 22 /PRNewswire-FirstCall/ - Bioniche Life ... Canadian biopharmaceutical company, today provided an update on ... the treatment of bladder cancer. On March 31st, ... in its initial Phase III registration trial evaluating ...
... to tumor growth for clues to better treatments , , FRIDAY, ... that levels of the protein caveolin-1 found in stromal connective ... patient,s prognosis and may provide a pathway to future treatments. ... in how cells absorb things, in the stromal cells were ...
... is what leads to well-being , , FRIDAY, May 22 (HealthDay ... may sound like a sure ticket to happiness, but a ... Rochester in New York tracked 147 college graduates, evaluating their ... one year after graduation, and then 12 months later. , ...
... these ingredients could be sent to manufacturers by month,s end ... H1N1 swine flu vaccine got a bit nearer Friday, with ... for use in such a shot. , "Today CDC received, ... CDC,s Interim Deputy Director for Science and Public Health Program ...
... Researchers at Roswell Park Cancer Institute (RPCI) in Buffalo, New ... to vaccinate both young men and women against HPV 16 ... growing evidence that certain cancers of the head and neck ... the human papillomavirus (HPV) that is one of the most ...
Cached Medicine News:Health News:Awareness Increases on New Health and Safety Technology for Kids 2Health News:Awareness Increases on New Health and Safety Technology for Kids 3Health News:Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well 2Health News:Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well 3Health News:Looks, Money, Fame Don't Bring Happiness 2Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 2Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 3Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 4Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 5Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 6Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 7Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 8Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 9Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 10Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 11Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 12Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 13Health News:Sexually Transmitted HPV Linked to Certain Head & Neck Cancers 2Health News:Sexually Transmitted HPV Linked to Certain Head & Neck Cancers 3
(Date:5/23/2013)... 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the 2013 Life Science Firm of the Year by the ... was honored at the TCM,s 25 th Annual Tech ... The Tech Awards Celebration recognizes the leaders and innovators in ... and the surrounding regions. "We ...
(Date:5/23/2013)... Amgen (NASDAQ: AMGN ) will present ... on Thursday, May 30, 2013, at the Westin Boston Waterfront ... Eastern Daylight Time. Arvind Sood , vice ... conference. Live audio of the presentation can be accessed from ... Investors. A replay of the webcast will also be available ...
(Date:5/23/2013)... Hearing health affects a man,s lifestyle, and if ... and professionally engaged, he should address any hearing loss he ... Better Hearing Institute (BHI) is delivering to men ... Week , which leads up to and includes Father,s Day. ... through June 16. To help men address ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4
... 2011 Pharmatek Laboratories, Inc., a premier contract ... announced that it has added spray drying to ... has purchased a Buchi B-290 Mini Spray Dryer ...  This technology can be used for both oral ...
... (NASDAQ: STXS ) today announced that executive management ... The Deutsche Bank Annual Health Care Conference ... of Stereotaxis, is scheduled to present an overview of the ... The JMP Securities Annual Research Conference in San Francisco. ...
Cached Medicine Technology:Pharmatek Laboratories Adds Spray Drying to Drug Development Services 2Stereotaxis to Present at Upcoming Investor Conferences 2Stereotaxis to Present at Upcoming Investor Conferences 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: